Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
ANAPTYSBIO, INC (ANAB)
Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
01/06/2023 | FENTON DENNIS M | Director | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | FENTON DENNIS M | Director | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Topper James N | 10% Owner | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Topper James N | 10% Owner | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | MULROY DENNIS | CFO | Grant | Stock Option (right to buy) | 57.3k | $23.23 | $1.3M | | 01/06/2023 |
01/06/2023 | MULROY DENNIS | CFO | Grant | Restricted Stock Unit | 21k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | RENTON HOLLINGS | Director | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | RENTON HOLLINGS | Director | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Schmid John P. | Director | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | Schmid John P. | Director | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | LOUMEAU ERIC J | COO, General Counsel | Grant | Stock Option (right to buy) | 60.5k | $23.23 | $1.4M | | 01/06/2023 |
01/06/2023 | LOUMEAU ERIC J | COO, General Counsel | Grant | Restricted Stock Unit | 22.2k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Faga Daniel | Interim CEO | Grant | Stock Option (right to buy) | 194.9k | $23.23 | $4.5M | | 01/06/2023 |
01/06/2023 | Faga Daniel | Interim CEO | Grant | Restricted Stock Unit | 71.4k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Lizzul Paul F. | Chief Medical Officer | Grant | Stock Option (right to buy) | 67.1k | $23.23 | $1.6M | | 01/06/2023 |
01/06/2023 | Lizzul Paul F. | Chief Medical Officer | Grant | Restricted Stock Unit | 24.6k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Ware J. Anthony | Director | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | Ware J. Anthony | Director | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Hamill Laura | Director | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | Hamill Laura | Director | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
01/06/2023 | Marquet Magda | Director | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | Marquet Magda | Director | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
09/14/2022 | Lizzul Paul F. | Chief Medical Officer | Grant | Restricted Stock Unit | 12k | $0.00 | $0 | | 09/14/2022 |
09/14/2022 | LOUMEAU ERIC J | COO, General Counsel | Grant | Restricted Stock Unit | 12k | $0.00 | $0 | | 09/14/2022 |
09/14/2022 | MULROY DENNIS | CFO | Grant | Restricted Stock Unit | 12k | $0.00 | $0 | | 09/14/2022 |
08/08/2022 | LOUMEAU ERIC J | COO, General Counsel | Sale | Common Stock | 523 | $25.00 | $13.1k | | 08/08/2022 |
06/23/2022 | LOUMEAU ERIC J | COO, General Counsel | Grant | Stock Option (right to buy) | 10k | $29.70 | $297k | | 06/23/2022 |
06/23/2022 | MULROY DENNIS | CFO | Grant | Stock Option (right to buy) | 10k | $29.70 | $297k | | 06/23/2022 |
06/23/2022 | Lizzul Paul F. | Chief Medical Officer | Grant | Stock Option (right to buy) | 10k | $29.70 | $297k | | 06/23/2022 |
06/08/2022 | LOUMEAU ERIC J | COO, General Counsel | Sale | Common Stock | 2.5k | $24.00 | $60k | | 06/08/2022 |
06/08/2022 | LOUMEAU ERIC J | COO, General Counsel | Exercise | Employee Stock Option (Right to Buy) | 2.5k | $14.02 | $35k | | 06/08/2022 |
05/18/2022 | LOUMEAU ERIC J | COO, General Counsel | Sale | Common Stock | 1.1k | $20.50 | $23.5k | | 05/18/2022 |
05/05/2022 | EcoR1 Capital, LLC | 10% Owner | Purchase | Common Stock | 668.2k | $21.63 | $14.5M | See Notes | 05/05/2022 |
05/05/2022 | EcoR1 Capital, LLC | 10% Owner | Sale | Common Stock | 668.2k | $21.63 | $14.5M | See Note | 05/05/2022 |
03/21/2022 | Faga Daniel | Interim CEO | Grant | Common Stock | 887k | $0.00 | $0 | | 03/21/2022 |
|
|